ストックスクリーナーアプリを入手
544.69
0.94%
-5.18
プレマーケット:
546.00
1.31
+0.24%
前日終値:
$549.87
開ける：
$545.5
24時間の取引高:
431.24K
Relative Volume:
0.84
時価総額：
$23.12B
収益：
$3.17B
当期純損益:
$1.29B
株価収益率:
20.10
EPS:
27.0947
ネットキャッシュフロー:
$1.01B
1週間 パフォーマンス:
+0.01%
1か月 パフォーマンス:
-3.58%
6か月 パフォーマンス:
+13.59%
1年 パフォーマンス:
+67.18%
1日の値動き範囲:
$544.02
$553.09
1週間の範囲:
$534.97
$553.09
52週間の値動き範囲:
$272.12
$609.35
United Therapeutics Corp Stock (UTHR) Company Profile
名前
United Therapeutics Corp
セクター
電話
(301) 608-9292
住所
1000 SPRING ST, SILVER SPRING, MD
Compare UTHR vs TAK, HLN, TEVA, ZTS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
544.69 | 23.34B | 3.17B | 1.29B | 1.01B | 27.09 |
TAK
Takeda Pharmaceutical Co Adr
|
15.74 | 49.29B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.89 | 40.34B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.26 | 39.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.82 | 33.30B | 9.51B | 2.64B | 2.14B | 6.0361 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 開始されました | Raymond James | Outperform |
| 2025-10-20 | 開始されました | Wells Fargo | Underweight |
| 2025-09-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-06-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | アップグレード | Goldman | Sell → Neutral |
| 2024-02-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2022-12-06 | 開始されました | UBS | Buy |
| 2022-12-05 | 開始されました | Goldman | Sell |
| 2022-10-11 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-20 | 繰り返されました | BofA Securities | Underperform |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-02-11 | 開始されました | BTIG Research | Neutral |
| 2021-07-14 | アップグレード | Argus | Hold → Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-02-01 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-06-25 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-03-10 | アップグレード | Jefferies | Hold → Buy |
| 2020-02-27 | アップグレード | Cowen | Market Perform → Outperform |
| 2020-01-31 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 開始されました | BofA/Merrill | Underperform |
| 2019-08-01 | アップグレード | Jefferies | Underperform → Hold |
| 2019-08-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | アップグレード | UBS | Sell → Neutral |
| 2019-05-09 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | アップグレード | Standpoint Research | Hold → Buy |
| 2018-08-08 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 繰り返されました | Barclays | Underweight |
| 2018-01-18 | 再開されました | Credit Suisse | Underperform |
| 2017-12-27 | 繰り返されました | Wedbush | Outperform |
| 2017-04-27 | 繰り返されました | Wedbush | Outperform |
| 2017-03-30 | 開始されました | UBS | Sell |
| 2017-03-16 | 開始されました | Credit Suisse | Underperform |
すべてを表示
United Therapeutics Corp (UTHR) 最新ニュース
Martine Rothblatt, United Therapeutics CEO, sells $5.2m in stock By Investing.com - Investing.com India
Martine Rothblatt, United Therapeutics CEO, sells $5.2m in stock - Investing.com
United Therapeutics CEO Rothblatt sells $5.47m in stock - Investing.com
UTHRUnited Therapeutics Corp Stock Price and Quote - Finviz
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report? - Yahoo Finance
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
MannKind develops inhaled ralinepag formulation for United Therapeutics - Investing.com
MannKind stock surges on United Therapeutics partnership deal - Investing.com
United Therapeutics EVP Mahon sells $4.54 million in stock - Investing.com UK
United Therapeutics Q1 2026 slides: IPF breakthrough offsets revenue miss - Investing.com
United Therapeutics EVP Mahon sells $4.54 million in stock By Investing.com - Investing.com Australia
United Therapeutics stock hits all-time high at 608.87 USD - Investing.com
UTHR Technical Analysis & Stock Price Forecast - Intellectia AI
UTHR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Xenotransplantation Explained: How Animal Organs Could Transform Medicine - News-Medical
Acute Respiratory Distress Syndrome Market to Grow - One News Page
Rothblatt (United Therapeutics) sells $5.3m in UTHR stock - Investing.com
Perspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study - The Manila Times
United Therapeutics CFO James Edgemond sells $5.48m in shares - Investing.com UK
United Therapeutics CEO Rothblatt sells $863,947 in stock By Investing.com - Investing.com Nigeria
United Therapeutics CEO Martine Rothblatt sells $5.2m in company stock - Investing.com Nigeria
United Therapeutics CFO James Edgemond sells $5.48m in shares By Investing.com - Investing.com India
United Therapeutics CEO Rothblatt sells $863,947 in stock - Investing.com
United Therapeutics CEO Martine Rothblatt sells $5.2m in company stock By Investing.com - Investing.com South Africa
Vanguard (VHT) Vs. Simplify (PINK): Which Healthcare ETF Is the Better Buy for Investors? - The Motley Fool
Simplify Health Care ETF (PINK) vs. Vanguard Health Care ETF (VHT): A Detailed ComparisonNews and Statistics - IndexBox
Liquidia Sinks 5% After Recent Rally - Bez Kabli
UTHR Stock Price, Quote & Chart | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill
United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 19.47% Potential Upside - DirectorsTalk Interviews
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock - Insider Monkey
United Therapeutics CEO Rothblatt exercises, sells $5.37m in stock - Investing.com UK
United Therapeutics CEO Rothblatt exercises, sells $5.37m in stock By Investing.com - Investing.com South Africa
United Therapeutics Corporation (UTHR) Latest Stock News & Headlines - Yahoo Finance
United Therapeutics Corp at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
United Therapeutics CEO Martine Rothblatt sells $5.38m UTHR shares - Investing.com India
United Therapeutics CEO Martine Rothblatt sells $5.38m UTHR shares By Investing.com - Investing.com India
United Therapeutics CEO Rothblatt sells $5.4m in common stock By Investing.com - Investing.com India
United Therapeutics Explores Pig Heart Transplants And Space Labs As Valuation Lags - Yahoo Finance
United Therapeutics Corp (UTHR) 財務データ
収益
当期純利益
現金流量
EPS
0.31%
0.78%
大文字化:
|
ボリューム (24 時間):